News
Dollar General ( DG) was the best-performing stock in the S&P 500 after the discount retailer beat profit and sales estimates ...
The E.U.’s universal healthcare policies make pharmaceuticals much more affordable relative to the U.S., meaning there could ...
Hims agreed to buy private European telehealth firm Zava, which operates in the U.K., Germany, France, and Ireland.
US telehealth group explores selling ‘compounded medications’ in new markets after buying London-based rival Zava ...
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced a significant step in its ...
2d
Zacks Investment Research on MSNInvestors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to KnowHims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...
Hims & Hers Health sees some volatility with revenue growth, 38% subscriber increase, and promising telehealth market demand.
The direct-to-consumer telehealth company said the workforce reduction is unrelated to its weight-loss drug sector.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results